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MutY and its human ortholog, MUTYH, repair a specific form of DNA damage: adenine mis-paired with the
oxidatively modified form of deoxyguanosine, 8-oxo-7,8-dihydro-20-deoxyguanosine. In a recent issue of
Chemistry & Biology, Brinkmeyer et al. utilized mutant forms of MutY to reveal the critical residues in MutY
that are required for this selectivity and specificity.Reactive oxygen species (ROS) con-
tribute both positively and negatively to
human health. In healthy cells, ROS are
critical intracellular signaling molecules,
such as during the innate immune re-
sponse to bacterial infection (West et al.,
2011). However, disregulation of ROS
metabolism leads to the accumulation of
DNA-damaging agents such as super-
oxide anions, hydroxyl radicals, and
hydrogen peroxide, which derive from
endogenous sources via cellular metab-
olism (e.g., oxidative phosphorylation,
microsomes, and NADPH oxidases) and
exogenous sources such as asbestos,
cigarette smoke, UV light, ionizing radia-
tion, pesticides, and related neurotoxins
such as paraquat. Depending on the
extent and type of ROS exposure, all
macromolecules in the cell are subject
to ROS-mediated damage, including
proteins, lipids, RNA, and DNA. The
DNA-damaging effects of ROS have a
clear impact on cellular function, genome
stability, and human health, thus leading
to cancer, cardiovascular and pulmonary
diseases, triplet-repeat expansion, organ
dysfunction, and neurodegenerative dis-
eases (Hoeijmakers, 2009). As such, it is
therefore not surprising that all cells
have developed intricate and redundant
DNA repair pathways to prevent the dele-
terious effects that can arise from oxida-
tively damaged DNA (Svilar et al., 2011).
The oxidatively modified form of deoxy-
guanosine in DNA is 8-oxo-7,8-dihydro-
20-deoxyguanosine (8-oxodG or OG)
(Figure 1A) and was first identified more
than 25 years ago (Kasai and Nishimura,
1984). Although now known to be one
of many oxidatively modified forms of
deoxyguanosine (Svilar et al., 2011), OG
is the most extensively studied oxidativelesion of guanine and is repaired by
the DNA glycosylase and base excision
repair (BER) enzyme OGG1 in humans
(Figure 1B) (Almeida and Sobol, 2007).
TheOG lesion does not cause a significant
block to DNA replication in mammalian
cells and, in general, the OG DNA lesion
is minimally cytotoxic. Failure to repair
the OG lesion by OGG1 is not necessarily
associated with disease or the onset of
cancer. Although there have been some
reports suggesting an increase in oxida-
tive stress-induced cancers associated
with defects in OGG1, the presence
of the OG lesion is highly mutagenic and
the predominant phenotype is due to
the mutations that are caused by repli-
cation past the OG lesion (Figure 1B).
The increase in mutations, mostly G to
T transversion mutations, arises from
efficient DNA synthesis past the lesion
and insertion of dAMP opposite the OG
DNA lesion followed by a second round
of replication (David et al., 2007). The
nuclear and mitochondrial replicative
and repair DNA polymerases can insert
both dAMP and dCMP opposite OG,
including DNA polymerase d, k, b, l,
and g (Svilar et al., 2011). To avoid the
deleterious G to T transversion mutations,
the OG-A mis-pair can be corrected
by another round of BER, this time initi-
ated by MUTYH (Figure 1B). Removal of
adenine in the OG-A mis-pair is followed
by repair via the BER pathway that
involves DNA synthesis and preferential
insertion of the correct C base mediated
by DNA polymerase b (Polß), as sug-
gested recently in a structural analysis of
a Polß ternary complex with OG/dCTP
(Krahn et al., 2003). Therefore, BER-
mediated repair initiated by MUTYH pref-
erentially leads to theOG-C base pair thatChemistry & Biology 19, March 23, 2012would then be available for repair initiated
by OGG1, preventing the accumulation of
G to T transversion mutations (Fig-
ure 1B). This combined action of OGG1
to remove OG in the OG-C mis-pair or
MUTYH to remove the A in the OG-A
mis-pair followed by a second round
of OGG1-mediated repair, is commonly
referred to as the GO pathway (Michaels
and Miller, 1992), where the cell has
developed an iterative process to prevent
mutations following formation of OG in
DNA. Clinically, it appears that MutY
(MUTYH) is the most significant of the
repair proteins in the GO pathway. Muta-
tions or defects in MUTYH are associated
with an increase in colorectal cancer, now
referred to as MUTYH-associated poly-
posis (MAP) (Chow et al., 2004), and as
expected, tumors that derive fromdefects
in MUTYH have an increase in G to T
mutations.
MUTYH activity is essential to prevent
oxidative damage-induced mutations
and the onset of MAP, and therefore,
a detailed understanding of the molecular
mechanism of MutY (MUTYH) and the
amino acid residues involved in catalysis
and lesion recognition will help define
the human mutations that may predis-
pose to disease (MAP). Thus, David
et al. (2007) have made significant con-
tributions toward understanding the
detailed molecular mechanism of MutY-
and MUTYH-mediated lesion removal. In
the recent issue of Chemistry & Biology,
Brinkmeyer et al. (2012) utilize (in vitro
and in vivo) mutant forms of MutY, mu-
tated in the glycosylase active site or
the OG binding domain, to reveal the
critical residues in MutY that are required
for the selectivity and specificity of the
enzyme to remove the ‘‘A’’ residue in anª2012 Elsevier Ltd All rights reserved 313
Figure 1. The Pivotal Role of MutY or MUTYH in the GO Pathway to Prevent Genomic or Mitochondrial DNA Mutations Mediated by
Oxidatively Damaged Deoxyguanosine
(A) The chemical structure of 20deoxyguanosine and the oxidatively-modified DNA lesion 8-oxo-7,8-dihydro-20deoxyguanosine (OG).
(B) Depiction of the GO pathway following formation of OG in DNA. The OG lesion can be directly repaired by BER, removing OG and replacing the lesion with the
normal G base. However, if the OG lesion is not repaired and cells undergo replication, the resultingOG-Amis-pair is also a substrate for BER, initiated by MutY
(MUTYH in humans). As suggested by Brinkmeyer et al. (2012), repair of the A opposite the OG lesion in vivo requires initial recognition of the OG lesion by MutY,
facilitated by the C-terminal OG recognition domain (residues 226–350), and the subsequent base removal via the glycosylase activity (requiring residues Asp138
and Glu37). Preferential insertion of C opposite the OG lesion by polymerase b (Polß) yields the OG-Cmis-pair, a substrate for OGG1-mediated BER. The avail-
ability of two separate BER processing steps avoids the accumulation of G to T transversion mutations following replication of theOG-Amis-pair, preventing the
onset of colorectal cancer.
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damage-induced mutations. This study
focuses on two critical active site residues
inMutY from Escherichia coli: Asp138 and
Glu37. Previous structural analyses sug-
gested that Asp138 and Glu37 were key
catalytic active site amino acid residues
and corresponded to two of the most
common MUTYH variants associated
with MAP onset. Kinetic analysis with
purified enzymes confirmed the critical
role of amino acid residue Asp138 in the
reaction mechanism and demonstrated
that Asp138 must be deprotonated to
stabilize the oxacarbenium ion transition
state intermediate. These studies also
confirmed the significance of Glu37 in
the enzymatic reaction because the
activity of the Glu37Asp mutant was
reduced 200-fold, as compared to the
wild-type (WT) enzyme. To confirm that
these two active site residues are essen-
tial in vivo, Brinkmeyer et al. (2012) devel-
oped a cellular OG-A repair assay in
which an OG-A containing reporter
plasmid was transfected into E. coli
strains expressing theWTMutY or mutant
MutY proteins with alterations in either314 Chemistry & Biology 19, March 23, 2012Asp138 or Gly37 or a deletion of the
C-terminal OG binding domain (residues
226–350). Analysis of the recovered
reporter plasmid provided a quantitative
readout of MutY-mediated repair. Similar
to the in vitro kinetic analyses, the in vivo
OG-A repair assay further supports the
critical role of Asp138 and Glu37 in the
enzymatic activity of MutY. However, it
was also noted that the Glu37Asp MutY
mutant, with 200-fold diminished enzy-
matic activity in vitro, exhibited close to
half the activity of the WT enzyme in vivo,
suggesting that even severely compro-
mised glycosylase activity could mediate
repair of the OG-A mis-pair within the
cellular environment. Conversely, the
MutYD226–350 mutants could not facili-
tate any measurable repair in vivo, con-
firming the need for OG recognition in
MutY-mediated repair of the OG-A mis-
pair. A similar observation was also
observed in a rifampicin complementa-
tion assay. Overall, these authors suggest
that mutations in the OG binding/recogni-
tion domain of MutY, and by inference,
the human counterpart MUTYH, may
predispose to disease (MAP) to a greaterª2012 Elsevier Ltd All rights reservedextent than those mutants within the
enzyme active site.
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